Abstract
The peroxisome proliferator-activated receptor-γ (PPARG) is a member of the nuclear hormone receptor superfamily that has attracted considerable attention as a candidate gene for gestational diabetes mellitus (GDM) based on its function as a key factor involved in the regulation of adipocyte differentiation as well as lipid and glucose metabolism and insulin sensitivity. Many studies have examined the association between P12A polymorphism (rs1801282) in the PPARG gene and risk of GDM, but the results have been inconsistent. To derive a more precise estimation of the relationship, a meta-analysis of 2,858 GDM patients and 6,890 controls from nine published case–control studies was performed. An overall random effects odds ratio of 0.89 (95 % confidence interval [CI]: 0.77–1.04, P = 0.15) was found for 12A allele. In the subgroup analysis by ethnicity, significantly decreased risks were found in East Asians, while no significant associations were detected among Caucasian and Middle Eastern populations. Similar results were also observed using dominant genetic model. This meta-analysis suggested an overall weak association between the P12A polymorphism and GDM risk among East Asians. However, additional very large-scale studies are warranted to provide conclusive evidence on the effects of the PPARG gene on risk of GDM.
Similar content being viewed by others
References
Metzger BE, Coustan DR (1998) Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care 21(Suppl 2):B161–B167
Aberg A, Rydhstroem H, Frid A (2001) Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in Southern Sweden. Am J Obstet Gynecol 184:77–83
King H (1998) Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 21(Suppl 2):B9–B13
Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM (2004) An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol 103:526–533
Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28:579–584
HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002
Löbner K, Knopff A, Baumgarten A, Mollenhauer U, Marienfeld S, Garrido-Franco M, Bonifacio E, Ziegler AG (2006) Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 55:792–797
Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773–1779
Michalik L, Auwerx J, Berger JP et al (2006) International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 58:726–741
Spiegelman BM (1998) PPAR-c: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507–514
Dubuquoy L, Dharancy S, Nutten S et al (2002) Role of peroxisome proliferator-activated receptor c and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360:1410–1418
Mukherjee R, Jow L, Croston GE et al (1997) Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARc2 versus PPARc1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 272:8071–8076
Fajas L, Debril MB, Auwerx J (2001) PPAR: an essential role in metabolic control. Nutr Metab Cardiovasc Dis 11:64–69
Deeb SS, Fajas L, Nemoto M et al (1998) A Pro12Ala substitution in PPAR2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284–287
Doney AS, Fischer B, Cecil JE, Boylan K, McGuigan FE, Ralston SH, Morris AD, Palmer CN (2004) Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes. Diabetologia 47:555–558
Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J, Amouyel P (1998) A genetic polymorphism of the peroxisome proliferator-activated receptor gene influences plasma leptin levels in obese humans. Hum Mol Genet 7:435–440
Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629–634
Heude B, Pelloux V, Forhan A et al (2011) Association of the Pro12Ala and C1431T variants of PPARgamma and their haplotypes with susceptibility to gestational diabetes. J Clin Endocrinol Metab 96:E1656–E1660
Pappa KI, Gazouli M, Economou K et al (2011) Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population. Gynecol Endocrinol 27:267–272
Cheng Y, Ma Y, Peng T, Wang J, Lin R, Cheng HD (2010) Genotype discrepancy between maternal and fetal Pro12Ala polymorphism of PPARG2 gene and its association with gestational diabetes mellitus. Zhonghua Fu Chan Ke Za Zhi 45:170–173
Cho YM, Kim TH, Lim S et al (2009) Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 52:253–261
Zhu Y, Wu Y (2009) Relationship between Prol2Ala polymorphism in peroxisome proliferators-activated receptor gamma 2 gene and gestational diabetes mellitus. Shi Yong Yi Xue Za Zhi 25:1963–1965 (in Chinese)
Lauenborg J, Grarup N, Damm P et al (2009) Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab 94:145–150
Shaat N, Lernmark A, Karlsson E et al (2007) A variant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus. Diabetologia 50:972–979
Tok EC, Ertunc D, Bilgin O, Erdal EM, Kaplanoglu M, Dilek S (2006) PPAR-gamma2 Pro12Ala polymorphism is associated with weight gain in women with gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 129:25–30
Shaat N, Ekelund M, Lernmark A et al (2004) Genotypic and phenotypic differences between Arabian and Scandinavian women with gestational diabetes mellitus. Diabetologia 47:878–884
Altshuler D, Hirschhorn JN, Klannemark M et al (2000) The common PPAR Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76–80
Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177–182
Tönjes A, Scholz M, Loeffler M, Stumvoll M (2006) Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor with pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care 29:2489–2497
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, C., Li, X., Huang, Z. et al. Quantitative assessment of the influence of PPARG P12A polymorphism on gestational diabetes mellitus risk. Mol Biol Rep 40, 811–817 (2013). https://doi.org/10.1007/s11033-012-2119-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-2119-5